The Lead Episode 59: A Discussion of Direct Oral Anticoagulants for Stroke Prevention in Patients with Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 ARTESiA Trials

Discussion Topic: Direct Oral Anticoagulants for Stroke Prevention in Patients with Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 ARTESiA Trials

Jason T. Jacobson, MD, FHRS, Westchester Medical Center-New York Medical College, is joined by William H. Sauer, MD, FHRS, Brigham and Women’s Hospital, and Christian Thomas Ruff, MD, Brigham and Women’s Hospital to discuss a meta-analysis of the 2 recent randomized controlled trials of oral anticoagulation vs aspirin and placebo for atrial high rate episodes detected by cardiac implanted electronic devices. The trials included are NOAH-AFNET6 and ARTESIA, which reported discordant results. When analyzed together, this study shows that anticoagulation does decrease embolic risk in this patient population.

Host: Jason T. Jacobson, MD, FHRS
Guests: William H. Sauer, MD, FHRS, CCDS and Christian Thomas Ruff, MD

Speaker and Article Information: Download

• Listen on HRS365
• Listen on Apple Podcasts
• Listen on Spotify
• Listen on iHeart